Patients with NAFLD had higher antioxidant enzyme activities (SOD, GPx, and CAT) in the liver cytosol whereas activities of those enzymes in erythrocytes did not differ compared to control [48]. The gene discussed is SOD1; the disease is metabolic dysfunction-associated steatotic liver disease.